July 26, 2016 8:07 AM ET

Healthcare Equipment and Supplies

Company Overview of Biodesix, Inc.

Company Overview

Biodesix, Inc., a molecular diagnostic company, discovers, develops, and commercializes cancer tests that help patients and their doctors to make informed decisions about the treatment based on a patient’s unique molecular profile. It offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer; VeriStrat, a serum proteomic test that provides physicians with prognostic and predictive information; and an epidermal growth factor receptor mutation status study in the non-small cell lung cancer. The company also operates a specialty laboratory to provide reflex testing to minimize turnaround time between genomic and proteomic testing. The company was form...

2970 Wilderness Place

Suite 100

Boulder, CO 80301

United States

Founded in 2005

Phone:

303-417-0500

Fax:

303-417-9700

Key Executives for Biodesix, Inc.

Chief Executive Officer and Director
Age: 57
Chief Financial Officer
Vice President of Product Development and Operations
Chief Business Officer
Chief Medical Officer
Age: 57
Compensation as of Fiscal Year 2016.

Biodesix, Inc. Key Developments

Biodesix, Inc. Presents at The Leerink Partners 5th Annual Global Healthcare Conference, Feb-11-2016 11:10 AM

Biodesix, Inc. Presents at The Leerink Partners 5th Annual Global Healthcare Conference, Feb-11-2016 11:10 AM. Venue: The Waldorf Astoria, New York, New York, United States. Speakers: David W. Brunel, Chief Executive Officer and Director.

Biodesix, Inc. Presents at JMP Securities Life Sciences Conference, Jun-23-2015 02:30 PM

Biodesix, Inc. Presents at JMP Securities Life Sciences Conference, Jun-23-2015 02:30 PM. Venue: The St. Regis New York, 2 East 55th Street, New York, NY 10022, United States.

Biodesix, Inc. Announces Executive Appointments

Biodesix, Inc. announced that Wendy Blosser is joining the company, and will serve as Vice President, Sales driving the sales of Biodesix expanding portfolio of blood-based tests in oncology. In addition, two other leaders have stepped into newly created roles: Jasmine Gruia-Gray, PhD. has assumed management of all marketing activities as the Vice President of Marketing and Robin Cowie has been promoted to the newly created role of Vice President, Reimbursement and Health Care Economics. Ms. Blosser is an oncology industry veteran who most recently held the position of US Vice President of Sales at Integrated Oncology. Ms. Cowie joined Biodesix in 2011 as the company's first director of reimbursement. Ms. Cowie's previous experience in reimbursement, payer and government affairs came during several years at Precision Therapeutics, Inc. Dr. Gruia-Gray joined Biodesix in 2014. Previously, she held the position of Vice President, Global Marketing at Affymetrix, Inc.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
September 25, 2015
--
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Biodesix, Inc., please visit www.biodesix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.